Polymorphisms of killer cell immunoglobulin-like receptor gene: Possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population

Croatian Medical Journal

Volumn 48, Issue 6, 2007, Pages 800-806

  Lu, Zhi Ming ^a   Jiao, Yu Lian ^a   Feng, Zhao Lei ^b   Wu, Chun Xiao ^a   Dong, Zhen Fang ^a   Zhang, Bing Chang ^a   Zhao, Yue Ran ^a  

^a SHANDONG UNIVERSITY   (China)

^b JINAN INFECTIOUS DISEASE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; IMMUNOGLOBULIN RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE; CLEARANCE; CONTROLLED STUDY; GENE ACTIVATION; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HUMAN; INFECTION SENSITIVITY; INFLAMMATION; KIR2DL4 GENE; KIR3DL2 GENE; KIR3DL3 GENE; KIRZ GENE; LIVER INJURY; MAJOR CLINICAL STUDY; NONHUMAN; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; RECEPTOR GENE; SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION; ASIAN; CASE CONTROL STUDY; COHORT ANALYSIS; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COHORT STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B, CHRONIC; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; RECEPTORS, KIR2DL4; RECEPTORS, KIR2DL5; RECEPTORS, KIR3DL2; RECEPTORS, KIR3DS1;

EID: 38449110614     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2007.6.800     Document Type: Article

References (25)

1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733-45. doi:10.1056/NEJM199712113372406
2. Thursz M. Genetic susceptibility in chronic viral hepatitis. Antiviral Res. 2001;52:113-6. doi:10.1016/S0166-3542(01)00175-9
3. Hann HW, Kim CY, London WT, Whitford P, Blumberg BS. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea. Int J Cancer. 1982;30:47-51. doi:10.1002/ijc.2910300109
4. Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, Lin CC, et al. Hepatitis B virus markers in Chinese twins. Anticancer Res. 1989;9:737-41.
5. Shimbo S, Zhang ZW, Qu JB, Wang JJ, Zhang CL, Song LH, et al. Urban-rural comparison of HBV and HCV infection prevalence among adult women in Shandong Province, China. Southeast Asian J Trop Med Public Health. 1997;28:500-6.
6. Yan LX, Zhu FM, Jiang K, He J. Diversity of the killer cell immunoglobulin-like receptor gene KIR2DS4 in the Chinese population. Tissue Antigens. 2007;69:133-8. doi:10.1111/j.1399-0039.2006.00746.x
7. Jiang K, Zhu FM, Lv QF, Yan LX. Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. Tissue Antigens. 2005;65:556-63. doi:10.1111/j.1399-0039.2005.00412.x
8. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med. 1995;182:875-84. doi:10.1084/jem.182.3.875
9. Martin AM, Freitas EM, Witt CS, Christiansen FT. The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics. 2000;51:268-80. doi:10.1007/s002510050620
10. Selvakumar A, Steffens U, Dupont B. Polymorphism and domain variability of human killer cell inhibitory receptors. Immunol Rev. 1997;155:183-96. doi:10.1111/j.1600-065X.1997.tb00951.x
11. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, et al. Human diversity in killer cell inhibitory receptor genes. Immunity. 1997;7:753-63. doi:10.1016/S1074-7613(00)80394-5
12. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol. 2002;20:217-50. doi:10.1146/annurev. immunol.20.092501.134942
13. Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med. 2001;193:1159-67. doi:10.1084/jem.193. 10.1159
14. Yen JH, Lin CH, Tsai WC, Wu CC, Ou TT, Hu CJ, et al. Killer cell immunoglobulin-like receptor gene's repertoire in rheumatoid arthritis. Scand J Rheumatol. 2006;35:124-7. doi:10.1080/03009740500381252
15. Martin MP, Nelson G, Lee JH, Pellett F, Gao X, Wade J, et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol. 2002;169:2818-22.
16. van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes. 2003;52:2639-42. doi:10.2337/diabetes.52.10.2639
17. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 2004;305:872-4. doi:10.1126/science.1097670
18. Deng G, Zhou G, Zhai Y, Li S, Li X, Li Y, et al. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology. 2004;40:318-26. doi:10.1002/hep.20318
19. Selvakumar A, Steffens U, Dupont B. Polymorphism and domain variability of human killer cell inhibitory receptors. Immunol Rev. 1997;155:183-96. doi:10.1111/j.1600-065X.1997.tb00951.x
20. Lowe EJ, Turner V, Handgretinger R, Horwitz EM, Benaim E, Hale G, et al. T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation. Br J Haematol. 2003;123:323-6. doi:10.1046/j.1365-2141.2003.04604.x
21. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med. 1995;332:1065-9. doi:10.1056/NEJM199504203321604
22. Höhler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol. 1997;26:503-7. doi:10.1016/S0168-8278(97)80414-X
23. Ahn SH, Han KH, Park JY, Lee CK, Kang SW, Chon CY, et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology. 2000;31:1371-3. doi:10.1053/jhep.2000.7988
24. Martin AM, Freitas EM, Witt CS, Christiansen FT. The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics. 2000;51:268-80. doi:10.1007/s002510050620
25. Bontadini A, Testi M, Cuccia MC, Martinetti M, Carcassi C, Chiesa A, et al. Distribution of killer cell immunoglobulin-like receptor genes in the Italian Caucasian population. J Transl Med. 2006;4:44. doi:10.1186/1479-5876-4- 44